Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/23833
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVerma, V-
dc.contributor.authorMediratta, P K-
dc.contributor.authorSharma, K K-
dc.date.accessioned2013-11-20T04:39:29Z-
dc.date.available2013-11-20T04:39:29Z-
dc.date.issued2001-07-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/23833-
dc.description636-642en_US
dc.description.abstractEffect of four calcium channel blockers (CCBs) belonging to different chemical classes, alone and in combination with morphine was investigated on two models of pain sensitivity, i.e. formalin and tail flick tests in mice. All the studied CCBs, i.e. diltiazem, flunarizine, nimodipine and verapamil inhibited formalin-induced pain responses; however, with verapamil, though there was a trend towards a reduction of paw-licking response to formalin, it was not found to be statistically significant. In contrast, none of the CCBs affected the tail flick latency at any of the doses studied. Morphine, a mu-receptor agonist exerted a significant analgesic effect in formalin as well in tail flick tests. Pretreatment with all CCBs significantly enhanced the analgesic effect of morphine in both tests of nociception. Further, concomitant administration of one of the CCBs, diltiazem with morphine prevented the development of tolerance to the latter. However, combination of diltiazem with morphine, like morphine alone was found to be ineffective in morphine tolerant animals. Results, thus, show that CCBs produced an analgesic effect of their own in formalin-induced tonic pain and potentiated the analgesic activity of morphine.  They also modulated opioid-induccd tolerance. en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.39(07) [July 2001]en_US
dc.titlePotentiation of analgesia and reversal of tolerance to morphine by calcium channel blockersen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.39(07) [July 2001]

Files in This Item:
File Description SizeFormat 
IJEB 39(7) 636-642.pdf1.54 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.